What is the market capitalization of Upstream Bio, Inc.?

Upstream Bio, Inc. (UPB) has a market capitalization of approximately 415,224,493 USD.

How many ETFs hold UPB?

UPB is held by 19 ETFs tracked on Investir en Bourse.

Where can I buy UPB in Canada?

UPB can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

UPB

Upstream Bio, Inc.

Upstream Bio, Inc. (UPB) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 415 million USD (small-cap).

Details

Price7.63 USD

Market cap415.22 M USD

Payout ratio0.00%

ROE-41.83%

Debt / Equity0.37%

SectorHealthcare

Websiteupstreambio.com

Updated a few minutes ago

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.